Completed NCT02202213
This summary needs review. Please check the official study record and contact the research team for details.
In Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 60 Years
Countries United States
Sponsor H. Lundbeck A/S
Condition Schizophrenia Completed NCT02202226
This summary needs review. Please check the official study record and contact the research team for details.
In Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United States
Sponsor H. Lundbeck A/S
Condition Schizophrenia Completed NCT01397786
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Canada, Colombia, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Terminated NCT02968121
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Garden Grove Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT01552772
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including Anaheim Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT00628420
This study is completed in the United States. It focuses on Schizophrenia.
In Dallas Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 20 Years to 50 Years
Countries United States
Sponsor University of Texas Southwestern Medical Center
Condition Schizophrenia Completed NCT00763438
This summary needs review. Please check the official study record and contact the research team for details.
In Allonnes Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries France
Sponsor H. Lundbeck A/S
Condition Schizophrenia Completed NCT00085748
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 65 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT01662648
This study is completed. It is testing Paliperidone Extended-Release (ER) for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Janssen Pharmaceutica
Condition Schizophrenia Completed NCT01879722
This study is completed in the United States. It is testing Multiple Rising Doses of TAK- 063 for schizophrenia.
In Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Takeda
Condition Schizophrenia Completed NCT03164876
This study is completed in the United Kingdom. It is testing AUT00206 for schizophrenia.
In London Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 50 Years
Countries United Kingdom
Sponsor Autifony Therapeutics Limited
Condition Schizophrenia Suspended NCT02724917
This study is suspended in the United States. It is testing APN1125 for schizophrenia.
In Long Beach Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 45 Years
Countries United States
Sponsor CoMentis
Condition Schizophrenia